Muscle Cell News Volume 8.10 | Mar 27 2023

    0
    40








    2023-03-27 | MUSCN 8.10


    Muscle Cell News by STEMCELL Technologies
    Vol. 8.10 – 27 March, 2023
    TOP STORY

    PCYT2-Regulated Lipid Biosynthesis Is Critical to Muscle Health and Aging

    The authors showed that the lipid synthesis enzyme phosphatidylethanolamine cytidyltransferase (PCYT2/ECT) was critical to muscle health.
    [Nature Metabolism]

    AbstractPress Release

    Listen to the Stem Cell Podcast episodes covering ISSCR 2022 sessions.
    PUBLICATIONSRanked by the impact factor of the journal

    A Defect in Mitochondrial Protein Translation Influences Mitonuclear Communication in the Heart

    The structure and function of mitochondria was disrupted in Mrps5 mutant cardiomyocytes, impairing mitochondrial protein translation, and OXPHOS.
    [Nature Communications]

    Full Article

    The Imbalance of p53–Park7 Signaling Axis Induces Iron Homeostasis Dysfunction in Doxorubicin-Challenged Cardiomyocytes

    Researchers demonstrated that doxorubicin challenge exhibited reduced contractile function and induction of ferroptosis-related phenotype in cardiomyocytes, evidenced by iron overload, lipid peroxide accumulation, and mitochondrial dysfunction.
    [Advanced Science]

    Full Article

    Indirect Epigenetic Testing Identifies a Diagnostic Signature of Cardiomyocyte DNA Methylation in Heart Failure

    Scientists determined whether patient plasma confered indirect phenotypic, transcriptional, and/or epigenetic alterations to ex vivo cardiomyocytes to mirror the failing human myocardium.
    [Basic Research in Cardiology]

    Full Article

    Large Maf Transcription Factor Family Is a Major Regulator of Fast Type IIb Myofiber Determination

    Investigators demonstrated that the large Maf transcription factor family dictates fast type IIb myofiber specification in mice.
    [Cell Reports]

    Full ArticleGraphical Abstract

    Differentiation of Patient-Specific Void Urine-Derived Human Induced Pluripotent Stem Cells to Fibroblasts and Skeletal Muscle Myocytes

    Researchers established a workflow using induced pluripotent stem cells (iPSC)-derived fibroblasts and skeletal myocytes for urethral tissue regeneration. Cells from voided urine of women were reprogrammed into iPSC.
    [Scientific Reports]

    Full Article

    Aging Disrupts MANF-Mediated Immune Modulation during Skeletal Muscle Regeneration

    Scientists uncovered a new mechanism of immune modulation operating during skeletal muscle regeneration that was disrupted in aged animals and relied on the regulation of macrophage function.
    [Nature Aging]

    Abstract

    Protective Role for Smooth Muscle Cell Hepcidin in Abdominal Aortic Aneurysm

    To probe the role of smooth muscle cell (SMC)-derived hepcidin in the setting of abdominal aortic aneurysm (AAA), the authors applied Angiotensin-II-induced AAA model to mice harboring an inducible, SMC-specific deletion of hepcidin.
    [Arteriosclerosis Thrombosis And Vascular Biology]

    Abstract

    BRG1 Is Involved in Vascular Calcification in Chronic Renal Disease via Autophagy of Vascular Smooth Muscle Cells

    The expression of Brahma related gene 1 (BRG1) was examined in high phosphorus stimulated rat aortic smooth muscle cells and calcified artery tissues from rat models and hemodialysis patients.
    [iScience]

    AbstractGraphical Abstract

    METTL3–METTL14 Complex Induces Necroptosis and Inflammation of Vascular Smooth Muscle Cells via Promoting N6 Methyladenosine mRNA Methylation of Receptor-Interacting Protein 3 in Abdominal Aortic Aneurysms

    Investigators identified whether the N6 methyladenosine writer METTL3/METTL4 regulated rip3 mRNA expression in abdominal aortic aneurysms.
    [Journal of Cell Communication and Signaling]

    AbstractGraphical Abstract
    Try proven workflows for your hPSC culture. Click to request your offer now.
    REVIEWS

    Cellular Reprogramming of Fibroblasts in Heart Regeneration

    Scientists summarize the reprogramming of fibroblasts into induced pluripotent stem cell-derived cardiomyocytes, induced cardiac progenitor cells, and induced cardiomyocytes to repair a damaged heart, and outline recent findings in utilizing fibroblast-derived cells for heart regeneration.
    [Journal of Molecular and Cellular Cardiology]

    AbstractGraphical Abstract
    INDUSTRY AND POLICY NEWS

    Amicus Therapeutics Announces European Commission Approval for Pombilitiâ„¢ in Patients with Late-Onset Pompe Disease

    Amicus Therapeutics announced that the European Commission has granted approval for Pombilitiâ„¢, a long-term enzyme replacement therapy used in combination with miglustat for adults with late-onset Pompe disease.
    [Amicus Therapeutics]

    Press Release

    FEATURED EVENT

    Integrative Molecular Epidemiology Workshop: Bridging Cancer Biology and Precision Medicine

    July 24 – 28, 2023
    Boston, Massachusetts, United States

    > See All Events

    JOB OPPORTUNITIES

    Associate Professor – Cardiovascular Research

    The University of Tennessee – Memphis, Tennessee, United States

    Senior Research Assistant – Skeletal Muscle

    Baylor College of Medicine – Houston, Texas, United States

    Postdoctoral Research Associate – Duchenne Muscular Dystrophy

    Icahn School of Medicine at Mount Sinai – New York, New York, United States

    Associate Research Scientist – Cardiac

    Columbia University – New York, New York, United States

    PhD Position – Muscle Physiology

    Hannover Medical School – Hanover, Germany

    > See All Jobs

    Submit (1)
    Brought to you by
    stemcell-logo-for newsletter-2
    Muscle Cell News Twitter